Literature DB >> 36175640

Assays for Determining the Sialidase Activity of Influenza Viruses and Monitoring Influenza Virus Susceptibility to Neuraminidase Inhibitors.

Emi Takashita1.   

Abstract

Three types of assays--colorimetric, fluorescent, and chemiluminescent--are used to determine the sialidase (neuraminidase: NA) activity of influenza viruses. The fluorescent assay is cost-effective and applicable for many laboratories and is, therefore, commonly used for global monitoring of the NA inhibitor susceptibility of influenza viruses. Here, I describe, in detail, protocols for the fluorescence-based NA activity assay and the NA inhibition assay, which are used to determine the NA activity and NA inhibitor susceptibility, respectively, of influenza viruses.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Influenza; Laninamivir; Neuraminidase; Neuraminidase inhibitor; Oseltamivir; Peramivir; Resistance; Sialidase; Zanamivir

Mesh:

Substances:

Year:  2022        PMID: 36175640     DOI: 10.1007/978-1-0716-2635-1_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018.

Authors:  Emi Takashita; Rod S Daniels; Seiichiro Fujisaki; Vicki Gregory; Larisa V Gubareva; Weiijuan Huang; Aeron C Hurt; Angie Lackenby; Ha T Nguyen; Dmitriy Pereyaslov; Merryn Roe; Magdi Samaan; Kanta Subbarao; Herman Tse; Dayan Wang; Hui-Ling Yen; Wenqing Zhang; Adam Meijer
Journal:  Antiviral Res       Date:  2020-01-28       Impact factor: 5.970

2.  Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays.

Authors:  Ha T Nguyen; Tiffany G Sheu; Vasiliy P Mishin; Alexander I Klimov; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

3.  Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en.

Authors:  L V Gubareva; M J Robinson; R C Bethell; R G Webster
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

4.  Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling.

Authors:  Marcel Jonges; Wai Ming Liu; Erhard van der Vries; Ronald Jacobi; Inge Pronk; Claire Boog; Marion Koopmans; Adam Meijer; Ernst Soethout
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

5.  Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016.

Authors:  Larisa V Gubareva; Terry G Besselaar; Rod S Daniels; Alicia Fry; Vicki Gregory; Weijuan Huang; Aeron C Hurt; Patricia A Jorquera; Angie Lackenby; Sook-Kwan Leang; Janice Lo; Dmitriy Pereyaslov; Helena Rebelo-de-Andrade; Marilda M Siqueira; Emi Takashita; Takato Odagiri; Dayan Wang; Wenqing Zhang; Adam Meijer
Journal:  Antiviral Res       Date:  2017-08-10       Impact factor: 5.970

6.  Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017.

Authors:  Angie Lackenby; Terry G Besselaar; Rod S Daniels; Alicia Fry; Vicki Gregory; Larisa V Gubareva; Weijuan Huang; Aeron C Hurt; Sook-Kwan Leang; Raphael T C Lee; Janice Lo; Lori Lollis; Sebastian Maurer-Stroh; Takato Odagiri; Dmitriy Pereyaslov; Emi Takashita; Dayan Wang; Wenqing Zhang; Adam Meijer
Journal:  Antiviral Res       Date:  2018-07-03       Impact factor: 5.970

Review 7.  Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.

Authors:  Aeron C Hurt; Terry G Besselaar; Rod S Daniels; Burcu Ermetal; Alicia Fry; Larisa Gubareva; Weijuan Huang; Angie Lackenby; Raphael T C Lee; Janice Lo; Sebastian Maurer-Stroh; Ha T Nguyen; Dmitriy Pereyaslov; Helena Rebelo-de-Andrade; Marilda M Siqueira; Emi Takashita; Masato Tashiro; Danielle Tilmanis; Dayan Wang; Wenqing Zhang; Adam Meijer
Journal:  Antiviral Res       Date:  2016-06-03       Impact factor: 5.970

8.  Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013.

Authors:  Adam Meijer; Helena Rebelo-de-Andrade; Vanessa Correia; Terry Besselaar; Renu Drager-Dayal; Alicia Fry; Vicky Gregory; Larisa Gubareva; Tsutomu Kageyama; Angie Lackenby; Janice Lo; Takato Odagiri; Dmitriy Pereyaslov; Marilda M Siqueira; Emi Takashita; Masato Tashiro; Dayan Wang; Sun Wong; Wenqing Zhang; Rod S Daniels; Aeron C Hurt
Journal:  Antiviral Res       Date:  2014-07-17       Impact factor: 5.970

9.  Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.

Authors:  Emi Takashita; Adam Meijer; Angie Lackenby; Larisa Gubareva; Helena Rebelo-de-Andrade; Terry Besselaar; Alicia Fry; Vicky Gregory; Sook-Kwan Leang; Weijuan Huang; Janice Lo; Dmitriy Pereyaslov; Marilda M Siqueira; Dayan Wang; Gannon C Mak; Wenqing Zhang; Rod S Daniels; Aeron C Hurt; Masato Tashiro
Journal:  Antiviral Res       Date:  2015-02-23       Impact factor: 10.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.